We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Fluorescent Nanotubes Provides Better Imaging of Mouse Innards

By LabMedica International staff writers
Posted on 08 Jun 2011
Researchers have devised an improved imaging method using fluorescent carbon nanotubes that allows them to see centimeters deep into a mouse with a lot more clarity than traditional dyes provide. More...
For an animal the size of a mouse, a few centimeters makes a great difference.

Developing drugs to fight or cure human disease frequently involves a phase of testing with mice, so being able to see clearly into a living mouse's insides has real benefits. However, with the fluorescent dyes now used to image the interior of laboratory mice, the view becomes so cloudy several millimeters under the skin that researchers do not have success extracting usable data.

"We have already used similar carbon nanotubes to deliver drugs to treat cancer in laboratory testing in mice, but you would like to know where your delivery went, right?" said Dr. Hongjie Dai, a professor of chemistry at Stanford University (Stanford, CA, USA; www.stanford.edu) . "With the fluorescent nanotubes, we can do drug delivery and imaging simultaneously--in real time--to evaluate the accuracy of a drug in hitting its target."

Researchers injected the single-walled carbon nanotubes into a mouse and watched as the tubes are delivered to internal organs by the bloodstream. The nanotubes fluoresce brightly in response to the light of a laser directed at the mouse, while a camera attuned to the nanotubes' near infrared wavelengths records the images. By attaching the nanotubes to an agent, researchers can see how the drug is progressing through the mouse's body.

Dr. Dai is the one of the authors of an article describing the research published online in May 2011 in the journal Proceedings of the [US] National Academy of Sciences (PNAS). The basis to the nanotubes' usefulness is that they shine in a different region of the near infrared spectrum than most dyes. Biologic tissues--whether mouse or human--naturally fluoresce at wavelengths below 900 nm, which is in the same range as the available biocompatible organic fluorescent dyes. That results in undesirable background fluorescence, which fogs the images when dyes are used. However, the nanotubes used by Dr. Dai's group fluoresce at wavelengths between 1,000 nm and 1,400 nm. At those wavelengths, there is barely any natural tissue fluorescence, so background "noise" is minimal.

The nanotubes usefulness is additionally enhanced because tissue scatters less light in the longer wavelength region of the near-infrared, reducing image smearing as light moves or travels through the body, another advantage over fluorophores emitting below 900 nm. "The nanotubes fluoresce naturally, but they emit in a very oddball region," Dr. Dai said. "There are not many things--living or inert--that emit in this region, which is why it has not been explored very much for biological imaging."

By selecting single-walled carbon nanotubes (SWNTS) with different chiralities diameters and other properties, Dr. Dai and his team can customize the wavelength at which the nanotubes fluoresce. The nanotubes are imaged immediately upon injection into the bloodstream of mice. Dr. Dai and graduate students Sarah Sherlock and Kevin Welsher, who are also coauthors of the PNAS article, observed the fluorescent nanotubes passing through the lungs and kidneys within seconds after injection. The spleen and liver lit up a few seconds later. The group also did some postproduction work on digital video footage of the circulating nanotubes to further enhance the image quality using a process called principal component analysis.

"In the raw imaging, the spleen, pancreas, and kidney might appear as one generalized signal," Ms. Sherlock said. "But this process picks up the subtleties in signal variation and resolves what at first appears to be one signal into the distinct organs."

"You can really see things that are deep inside or blocked by other organs such as the pancreas," Dr. Dai noted.

There are some other imaging methods that can produce deep tissue images, such as magnetic resonance imaging (MRI) and computer tomography (CT) scans. However, fluorescence imaging is widely used in research, and it requires simpler methods.

According to Dr. Dai, that the fluorescent nanotubes are not capable of reaching the depth of CT or MRI scans, but nanotubes are a step forward in widening the potential uses of fluorescence as an imaging system beyond the surface and near-surface applications it has been restricted to up until now.

Since nanotube fluorescence was discovered about 10 years ago, researchers have been trying to make the fluorescence brighter, according to Dr. Dai. However, he has been a little surprised at just how well they now work in animals. "I did not imagine they could really be used in animals to get deep images like these," he said. "When you look at images like this, you get a sense that the body almost has some transparency to it."

Related Links:

Stanford University




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.